Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:50:18.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:31.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Access to the study record page now shows a 403 Forbidden error, replacing the expected content. This indicates the record is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-20T20:30:07.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The study record now lists NIH grant/contract notes for 2019 and 2023. The page shows an updated revision tag, Revision: v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T06:16:55.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    No textual changes were provided in the change data, so the page content remains unchanged based on the input.
    Difference
    0.0%
    Check dated 2026-08-23T02:58:24.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now displayed on the page, replacing the prior version. This indicates a minor, system-level update to the page rather than a substantive change to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-08T23:15:17.000Z thumbnail image

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.